Back to Journals » Therapeutics and Clinical Risk Management » Volume 16

Original Research

Comparative Treatment Patterns and Outcomes of Fulvestrant versus Everolimus Plus Exemestane for Postmenopausal Metastatic Breast Cancer Resistant to Aromatase Inhibitors in Real-World Experience

       
Total article views   HTML views PDF downloads Totals
6,994 Dovepress* 6,363+ 1,025 7,388
PubMed Central* 631 175 806
Totals 6,994 1,200 8,194
*Since 30 June 2020
Total mentioned Facebook Delicious Reddit Twitter Others
2 0 0 0 0 2

View citations on PubMed Central and Google Scholar